The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Eydelman Mikhail since 2023.
This trader's CIK number is 1918033.
At the time of last reporting, Eydelman Mikhail was the SVP, GEN COUNSEL & CORP SEC of Vaxcyte, Inc.. (stock ticker symbol PCVX).
Also see all insider trading activities at Vaxcyte, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PCVX | 0 | $0 | 15,000 | $1,234,455 | 15,000 | $321,150 |
| 2024 | PCVX | 0 | $0 | 30,502 | $2,956,319 | 30,502 | $653,045 |
| 2023 | PCVX | 0 | $0 | 30,000 | $1,573,259 | 30,000 | $642,300 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-05 | PCVX | Option Ex | 5,000 | 21.41 | 107,050 |
| 2025-03-05 | PCVX | Sale | 5,000 | 71.28 | 356,375 |
| 2025-02-05 | PCVX | Option Ex | 5,000 | 21.41 | 107,050 |
| 2025-02-05 | PCVX | Sale | 5,000 | 89.91 | 449,565 |
| 2025-01-06 | PCVX | Sale | 5,000 | 85.70 | 428,515 |
| 2025-01-06 | PCVX | Option Ex | 5,000 | 21.41 | 107,050 |
| 2024-12-05 | PCVX | Sale | 5,000 | 91.66 | 458,295 |
| 2024-12-05 | PCVX | Option Ex | 5,000 | 21.41 | 107,050 |
| 2024-11-05 | PCVX | Option Ex | 5,000 | 21.41 | 107,050 |
| 2024-11-05 | PCVX | Sale | 5,000 | 106.21 | 531,040 |
| 2024-10-07 | PCVX | Option Ex | 5,000 | 21.41 | 107,050 |
| 2024-10-07 | PCVX | Sale | 5,000 | 109.59 | 547,930 |
| 2024-10-01 | PCVX | Sale | 5,500 | 114.25 | 628,397 |
| 2024-10-01 | PCVX | Option Ex | 5,500 | 21.41 | 117,755 |
| 2024-09-03 | PCVX | Option Ex | 1,667 | 21.41 | 35,690 |
| 2024-09-03 | PCVX | Sale | 1,667 | 112.94 | 188,274 |
| 2024-08-01 | PCVX | Option Ex | 1,667 | 21.41 | 35,690 |
| 2024-08-01 | PCVX | Sale | 1,667 | 79.04 | 131,764 |
| 2024-06-03 | PCVX | Option Ex | 1,667 | 21.41 | 35,690 |
| 2024-06-03 | PCVX | Sale | 1,667 | 72.42 | 120,720 |
| 2024-05-01 | PCVX | Option Ex | 1,667 | 21.41 | 35,690 |
| 2024-05-01 | PCVX | Sale | 1,667 | 62.38 | 103,992 |
| 2024-03-01 | PCVX | Sale | 1,667 | 73.80 | 123,016 |
| 2024-03-01 | PCVX | Option Ex | 1,667 | 21.41 | 35,690 |
| 2024-02-01 | PCVX | Sale | 1,667 | 73.72 | 122,891 |
| 2024-02-01 | PCVX | Option Ex | 1,667 | 21.41 | 35,690 |
| 2023-12-07 | PCVX | Option Ex | 10,000 | 21.41 | 214,100 |
| 2023-12-07 | PCVX | Sale | 10,000 | 56.50 | 565,000 |
| 2023-10-02 | PCVX | Option Ex | 20,000 | 21.41 | 428,200 |
| 2023-10-02 | PCVX | Sale | 20,000 | 50.41 | 1,008,259 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Eydelman Mikhail (SVP, GEN COUNSEL & CORP SEC of Vaxcyte, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.